Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04728295 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)

StatusActive, Not Recruiting
PhaseNot applicable
SponsorInSightec
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date changed from estimate of Apr 1, 2023 to Mar 28, 2024 Completion date: Apr 1, 2024 to Dec 1, 2028v12 Show 1 more changeShow less
    • Completion date: Apr 1, 2024 to Dec 1, 2028
  2. Trial status: Recruiting to Active, Not Recruiting Site details revised at 9 of 9 sitesv11 Show 1 more changeShow less
    • Site details revised at 9 of 9 sites
  3. Study sites: 7 to 9v10
  4. Study sites: 6 to 7v9
  5. Primary completion date: Jan 1, 2022 to Apr 1, 2023 Study sites: 5 to 6 · Completion date: Jan 1, 2023 to Apr 1, 2024 · Eligibility criteria shortened, about 191 words · 1 morev8 Show 4 more changesShow less
    • Study sites: 5 to 6
    • Completion date: Jan 1, 2023 to Apr 1, 2024
    • Eligibility criteria shortened, about 191 words
    • Study description revised

    See this version in full on ClinicalTrials.gov ↗

Show 6 earlier versionsHide 6 earlier versions
  1. Site details revised at 1 of 5 sitesv7
  2. Study sites: 3 to 5v6
  3. Study sites: 2 to 3v5
  4. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of May 1, 2021 to May 14, 2021 · Site details revised at 2 of 2 sitesv4 Show 2 more changesShow less
    • Start date changed from estimate of May 1, 2021 to May 14, 2021
    • Site details revised at 2 of 2 sites
  5. Study sites: 0 to 2v3
  6. Start date: Feb 1, 2021 to May 1, 2021v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
InSightec
42 trials monitored
See 1 trial at risk
Parkinson's Disease
1,435 trials monitored
See 62 trials at risk
Evaluate the Safety and Effectiveness of Staged Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD).
Trial Details
NCT Number NCT04728295
Lead Sponsor InSightec
Conditions Parkinson Disease
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov